Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN23 in Adults with X-Linked Hypophosphatemia
NCT01340482Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Apr 2011
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of burosumab in X-linked hypophosphatemia (XLH), sponsored by Kyowa Kirin. Started Apr 2011; status: completed.
02
Drugs
burosumab
03
Conditions
X-linked hypophosphatemia (XLH)
Beyond the preview
Go deeper on NCT01340482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340482.